報價延遲最少15分鐘:2026/07/05 01:58 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.38 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
51.42/63.32
|
|
企業價值
23.85B
|
| 資產負債 |
|
每股賬面淨值
4.80
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
245.88B
|
|
每股收益
3.85
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%).Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand nameand earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries. |
